Omada Health, Inc. (OMDA)
Nasdaq: OMDA · Services-Health Services · South San Francisco, CA · filing with the SEC since 2014
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
| Report filed | Mar 6, 2026 | · | · |
| Revenue | 260,210 | 169,800 | 122,784 |
| Cost of revenue | 89,271 | 66,923 | 52,813 |
| Gross profit | 170,939 | 102,877 | 69,971 |
| Research and development | 40,683 | 35,923 | 33,738 |
| Sales and marketing | 90,044 | 68,053 | 66,249 |
| General and administrative | 52,184 | 42,555 | 35,981 |
| Total operating expenses | 182,911 | 146,531 | 135,968 |
| Operating income | -11,972 | -43,654 | -65,997 |
| Interest expense | 2,534 | 4,506 | 4,705 |
| Interest and investment income | 5,305 | 805 | 5,775 |
| Total non-operating income (expense) | -806 | -3,483 | -1,514 |
| Income before income taxes | -12,778 | -47,137 | -67,511 |
| Income tax expense | 0 | 0 | 0 |
| Net income | -12,778 | -47,137 | -67,511 |
| Earnings per share, basic | -0.35 | -6.11 | -9.52 |
| Earnings per share, diluted | -0.35 | -6.11 | -9.52 |
| Weighted average shares, basic | 36,639 | 7,721 | 7,091 |
| Weighted average shares, diluted | 36,639 | 7,721 | 7,091 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSales and marketing the cost of finding and serving customers
us-gaap:SellingAndMarketingExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding